1435PBevacizumab as first-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC) in patients aged over 65 years in France: Final results of the AVANTAGE study. (23rd October 2018) - Lionel, F; Perol, D; Souquet, P-J; Le Caer, H; Dansin, E; Audigier Valette, C; Mouysset, J-L; Uffredi, M L; Ionescu-Goga, M; Veerabudun, K; Lelarge, Y; Fabre-Guillevin, E